Clinical Trials Browser

Phase 1/2 × Colorectal Neoplasms × Immune Checkpoint Inhibitors × Clear all

NCT06710847 2026-02-02

SYLVER

Phase 1/2 Active not recruiting

GastrointestinalGynecologic

Turcot syndrome, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT04110093 2020-12-30

Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer

Phase 1/2 Unknown

Gastrointestinal

Colorectal Neoplasms